RP Investment Advisors’s ProKidney PROK Stock Holding History

RP Investment Advisors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-538,848	Closed	-$5.33M	–	160
2021 Q4	$5.33M	Buy	+538,848	New	+$5.33M	0.66%	70

Other funds holding PROK

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

RP Investment Advisors's PROK Position: Q1 2022 in Review

RP Investment Advisors sold out of ProKidney (PROK) in Q1 2022, closing a stake of 538,848 shares — an estimated $5.33M sold.

RP Investment Advisors first reported a position in PROK in Q4 2021 and held it in 1 quarter. The position peaked at $5.33M in Q4 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.

RP Investment Advisors reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
RP Investment Advisors sold 538,848 ProKidney shares in Q1 2022, an estimated $5.33M.
RP Investment Advisors first reported a position in ProKidney in Q4 2021 and held it in 1 quarter.
RP Investment Advisors's ProKidney position peaked at $5.33M in Q4 2021.
80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.

Based on RP Investment Advisors's 13F filing for Q1 2022, filed 16 May 2022.